Navigation Links
Vanda Pharmaceuticals Reports Third Quarter 2009 Results
Date:11/2/2009

ROCKVILLE, Md., Nov. 2 /PRNewswire-FirstCall/ -- Vanda Pharmaceuticals Inc. (Vanda) (Nasdaq: VNDA), a biopharmaceutical company focused on the development and commercialization of clinical-stage products for central nervous system disorders, today announced financial and operational results for the third quarter ended September 30, 2009.

Vanda reported a net loss of $7.7 million for the third quarter of 2009, compared to $12.4 million for the second quarter of 2009 and $10.9 million for the third quarter of 2008. Total expenses for the third quarter of 2009 were $7.7 million, compared to $12.4 million for the second quarter of 2009 and $11.2 million for the third quarter of 2008. Research and development (R&D) expenses for the third quarter of 2009 were $2.1 million, compared to $7.2 million for the second quarter of 2009 and $3.8 million for the third quarter of 2008. The decrease in R&D expenses in the third quarter of 2009 relative to the second quarter of 2009 is primarily due to the regulatory consulting fees accrued in the second quarter as a result of the approval of Fanapt(TM) (iloperidone) by the U.S. Food and Drug Administration (FDA). The decrease in R&D expenses in the third quarter of 2009 relative to the third quarter of 2008 is primarily due to the completion of the Phase III clinical trial of tasimelteon in chronic primary insomnia in 2008.

As of September 30, 2009, Vanda's cash, cash equivalents, and marketable securities totaled approximately $20.7 million. As of September 30, 2009, a total of approximately 27.2 million shares of Vanda common stock were outstanding. Net loss per common share for the third quarter of 2009 was $0.28, compared to $0.46 for the second quarter of 2009 and $0.41 for the third quarter of 2008.

OPERATIONAL HIGHLIGHTS

On Octobe
'/>"/>

SOURCE Vanda Pharmaceuticals Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12

Related medicine news :

1. Vanda Pharmaceuticals to Announce Third Quarter 2009 Financial Results on November 2, 2009
2. Vanda Pharmaceuticals Announces Date of Annual Meeting of Stockholders
3. Vanda Pharmaceuticals Announces Withdrawal of Director Nominees and Proposal to Liquidate Submitted by Tang Capital
4. Vanda Pharmaceuticals Responds to Announcement and Filing by a Group Led by Tang Capital Partners, LP
5. FDA Accepts Vanda Pharmaceuticals Iloperidone Resubmission and Sets New Action Date
6. Vanda Pharmaceuticals Announces Receipt of Not Approvable Letter From FDA for Iloperidone
7. Vanda Pharmaceuticals to Present at the FBR Capital Markets 12th Annual Spring Investor Conference
8. Vanda Pharmaceuticals Announces that it No Longer Intends to Offer Convertible Senior Notes
9. Vanda Pharmaceuticals VSF-173 Excessive Sleepiness Phase II Clinical Trial Suggests Wake-Promoting Properties
10. Vanda Pharmaceuticals to Announce Third Quarter 2007 Financial Results on November 8, 2007
11. Vanda Pharmaceuticals to Present New Data on Iloperidone at the 2007 American Society of Human Genetics Annual Meeting
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/21/2014)... Angeles, CA (PRWEB) August 21, 2014 ... talk show “Heavy Metal Greg” will screen on Monday, ... Action on Film International Film Festival. This festival is ... several companies, including Video Symphony, Sony Software, Avid, and ... California, at Cinema 12 & LFX, located at 410 ...
(Date:8/21/2014)... Researchers and health authorities need to ensure that experimental ... the context of randomized controlled trials, according to a ... [Thursday 21 August, 2014]. , Leading bioethicists ... USA, and Dr Annette Rid, of King,s College London, ... adhered to if experimental drugs are to be deployed ...
(Date:8/21/2014)... One of the emerging trends that ... is an increasing adoption of non-invasive administration products. As ... patient through their convenient application, they find more preference ... medical device used for the administration of drugs for ... paranasal sinus such as allergic and non-allergic rhinitis and ...
(Date:8/21/2014)... 21, 2014 According to a new ... Market - Global Industry Analysis, Size, Share, Growth, Trends ... market was valued at USD 236.1 million in 2011 ... 358.3 million in 2018 at a CAGR of 6.3% ... Cameras Market Report: http://www.transparencymarketresearch.com/fundus-cameras.html . , Fundus cameras ...
(Date:8/21/2014)... Angeles, CA (PRWEB) August 21, 2014 Sleep ... doctors across the U.S. This provides doctors with a convenient ... who find a doctor are that much closer to finding ... condition have no idea they are experiencing this sleep ... not receive treatment at all. , Thanks to Sleep Apnea ...
Breaking Medicine News(10 mins):Health News:“Heavy Metal Greg,” a Music Talk Show by Gregory Graham, Will Screen at Action on Film International Film Festival on 08/25/2014 2Health News:The Lancet: Experimental Ebola drugs must be fairly distributed and tested ethically in clinical trials 2Health News:Intranasal Drug Delivery Market 2014 – 2018 Global Forecasts and Analysis in New Research Report at Sandlerresearch.org 2Health News:Intranasal Drug Delivery Market 2014 – 2018 Global Forecasts and Analysis in New Research Report at Sandlerresearch.org 3Health News:Intranasal Drug Delivery Market 2014 – 2018 Global Forecasts and Analysis in New Research Report at Sandlerresearch.org 4Health News:Intranasal Drug Delivery Market 2014 – 2018 Global Forecasts and Analysis in New Research Report at Sandlerresearch.org 5Health News:Fundus Cameras Market: Product Type- Mydriatic, Non-Mydriatic, Hybrid and ROP Cameras; End Users- Hospitals, Ophthalmology Clinics and Ophthalmic & Optometrist Offices 2Health News:Sleep Apnea Doctors US is Now Offering Complimentary Listings to Sleep Apnea Doctors Across the United States 2
... Delaware,s Partnership to Fight Chronic Disease (PFCD), a coalition committed ... of comprehensive health reform, hosted a breakfast meeting today where ... management and care. , , America spends ... 75 percent - or $1.7 trillion - of that spending ...
... 22 Communication Awards in 6 Months- , , ... effort to help consumers understand their health care options, Blue ... the last six months. The not-for-profit plan won awards from ... Advertisers, that acknowledge the company,s website design, marketing programs and ...
... , The event was an unmitigated success, welcoming 1012 visitors who ... , SAO PAULO, June 30 A ... South America Summit , held for the first time ... international conference and tabletop exhibition welcomed over 1000 key decision-makers in ...
... that men and women who feel sensitive to rejection based ... in having cosmetic surgery than those who are less sensitive ... people recall negative comments about their physical appearance. ... of the journal Body Image , was conducted by ...
... Agency Honored for Interactive and Marketing Effectiveness Campaigns , ... Cadient Group , the premier strategic interactive ... it was recognized for nine campaigns at the ... won five Gold Awards of Excellence in the Email ...
... medical device company Intelligent Hospital Systems (IH Systems) ... the Computerworld Honors Program Awards Gala on June ... the award in recognition of its RIVA System ... software, robotics and engineering to automate IV preparation ...
Cached Medicine News:Health News:Delaware's Partnership to Fight Chronic Disease Breakfast Highlights Promising Practices in Managing Chronic Disease Provides Solutions for Reduced Spending and Improved Patient Health 2Health News:Blue Shield of California Makes Understanding Health Care Issues Easier for Consumers 2Health News:Blue Shield of California Makes Understanding Health Care Issues Easier for Consumers 3Health News:Food Ingredients Industry Leaders Applaud the Launch of Health ingredients South America 2Health News:Food Ingredients Industry Leaders Applaud the Launch of Health ingredients South America 3Health News:Food Ingredients Industry Leaders Applaud the Launch of Health ingredients South America 4Health News:Cosmetic surgery appeals to men, women with appearance-based rejection sensitivity 2Health News:Cadient Group Wins Nine Communicator Awards 2Health News:Cadient Group Wins Nine Communicator Awards 3Health News:Intelligent Hospital Systems Receives International Award for Innovative Technology Benefiting Society 2
(Date:8/21/2014)... Aug. 21, 2014 /PRNewswire-iReach/ -- Inc. ... for the third straight year, No. 349 in ... exclusive ranking of the nation,s fastest-growing private companies. ... the most important segment of the economy—America,s independent ... Domino,s Pizza, LinkedIn, Zillow, and many other well-known ...
(Date:8/21/2014)... 2014 /PRNewswire-iReach/ -- ScriptPro has been certified by ... Common Security Framework (CSF). According to Russ ... "We appreciate this rigorous, top-to-bottom audit. Security-minded customers ... certification signifies. Our business partners need to know ... CERTIFICATION PROCESS: ScriptPro,s internal security processes and controls ...
(Date:8/21/2014)... , Aug. 21, 2014  Zacks.com announces the list of ... Equity Research analysts discuss the latest news and events impacting ... blog include the Hewlett-Packard (NYSE: HPQ - Free Report ), ... Inc. (NYSE: SB - Free Report ), GlaxoSmithKline plc ... N.V. (NYSE: FI - Free Report ). ...
Breaking Medicine Technology:Carolina's HME Named for Third Straight Year to Inc. Magazine's List of America's Fastest-Growing Private Companies--the Inc. 5000 2Carolina's HME Named for Third Straight Year to Inc. Magazine's List of America's Fastest-Growing Private Companies--the Inc. 5000 3ScriptPro Achieves HITRUST Certification 2The Zacks Analyst Blog Highlights: Hewlett-Packard, IBM, Safe Bulkers, GlaxoSmithKline and Frank's International 2The Zacks Analyst Blog Highlights: Hewlett-Packard, IBM, Safe Bulkers, GlaxoSmithKline and Frank's International 3The Zacks Analyst Blog Highlights: Hewlett-Packard, IBM, Safe Bulkers, GlaxoSmithKline and Frank's International 4The Zacks Analyst Blog Highlights: Hewlett-Packard, IBM, Safe Bulkers, GlaxoSmithKline and Frank's International 5The Zacks Analyst Blog Highlights: Hewlett-Packard, IBM, Safe Bulkers, GlaxoSmithKline and Frank's International 6The Zacks Analyst Blog Highlights: Hewlett-Packard, IBM, Safe Bulkers, GlaxoSmithKline and Frank's International 7The Zacks Analyst Blog Highlights: Hewlett-Packard, IBM, Safe Bulkers, GlaxoSmithKline and Frank's International 8The Zacks Analyst Blog Highlights: Hewlett-Packard, IBM, Safe Bulkers, GlaxoSmithKline and Frank's International 9The Zacks Analyst Blog Highlights: Hewlett-Packard, IBM, Safe Bulkers, GlaxoSmithKline and Frank's International 10The Zacks Analyst Blog Highlights: Hewlett-Packard, IBM, Safe Bulkers, GlaxoSmithKline and Frank's International 11
... MINNEAPOLIS, Aug. 2, 2011 Techne Corporation,s (NASDAQ: ... year ended June 30, 2011 include the following highlights: , ... million or $.76 per diluted share.  Earnings for the quarter ... when adjusted for intangible asset amortization, costs recognized upon the ...
... SAN DIEGO and WOODCLIFF LAKE, N.J., Aug. 2, 2011 ... Inc. announced today the completion of a clinical ... and plasma and related data analyses. The study was conducted ... the human relevance of the observation of brain astrocytoma in ...
Cached Medicine Technology:Techne Corporation Releases Unaudited Fourth Quarter and Fiscal Year 2011 Results 2Techne Corporation Releases Unaudited Fourth Quarter and Fiscal Year 2011 Results 3Techne Corporation Releases Unaudited Fourth Quarter and Fiscal Year 2011 Results 4Techne Corporation Releases Unaudited Fourth Quarter and Fiscal Year 2011 Results 5Techne Corporation Releases Unaudited Fourth Quarter and Fiscal Year 2011 Results 6Techne Corporation Releases Unaudited Fourth Quarter and Fiscal Year 2011 Results 7Techne Corporation Releases Unaudited Fourth Quarter and Fiscal Year 2011 Results 8Techne Corporation Releases Unaudited Fourth Quarter and Fiscal Year 2011 Results 9Techne Corporation Releases Unaudited Fourth Quarter and Fiscal Year 2011 Results 10Techne Corporation Releases Unaudited Fourth Quarter and Fiscal Year 2011 Results 11Arena and Eisai Announce Completion of Study Measuring Lorcaserin Concentrations in Human Cerebrospinal Fluid and Related Analyses 2Arena and Eisai Announce Completion of Study Measuring Lorcaserin Concentrations in Human Cerebrospinal Fluid and Related Analyses 3Arena and Eisai Announce Completion of Study Measuring Lorcaserin Concentrations in Human Cerebrospinal Fluid and Related Analyses 4Arena and Eisai Announce Completion of Study Measuring Lorcaserin Concentrations in Human Cerebrospinal Fluid and Related Analyses 5Arena and Eisai Announce Completion of Study Measuring Lorcaserin Concentrations in Human Cerebrospinal Fluid and Related Analyses 6
The Volk 60D provides high magnification - making it ideal for detailed disc and macular viewing. Its 31mm diameter facilitates easy handling within the orbital area. Available with SupraCoat (argon...
The 40D is ideal for pediatric ophthalmoscopy and other examinations requiring expansive fundus visibility. Alternatively, this lens may be used at the slit lamp biomicroscope to provide an extremely...
Provides exceptional resolution and fundus scanning capability. Excellent for small pupil diagnosis and treatment....
... lens is perfectly corrected for field ... delivering the best retinal image of ... market. Its advanced double aspheric design ... perfect image clarity across the entire ...
Medicine Products: